Scientists suggest findings highlight potential targets and could lead to the development of therapies that specifically block the tumor’s ability to spread.
The bump had been present for about 3 months. The patient’s mother said there had been no bleeding, tenderness, color change, ...
NGF pathway drives tumour growth. Innate lymphoid cells type 2 (ILC2s) are key regulators of tissue homeostasis and ...
Background High serum levels of interleukin 6 (IL-6) predict poor prognosis in intrahepatic cholangiocarcinoma (iCCA), a ...
Amphista Therapeutics (“the Company” or “Amphista”), a leader in the discovery and development of non-cereblon/non-VHL Targeted Glue™ degraders, today announces three upcoming presentations at the ...
Leukaemia is cancer of the blood-forming tissue, including the bone marrow and the lymphatic system. It is characterised by ...
Akeso, Inc. (9926.HK) ('Akeso' or the 'Company') announced today that its proprietary first-in-class trispecific antibody, ...
Maya and Angus both survived childhood cancer, but the treatments that saved their lives left them with chronic health issues ...
Initiated US Phase 1/2a study of DLL3-targeting 212Pb-based Radio-DARPin candidate MP0712 for SCLC and other neuroendocrine cancers, co-developed ...
Taking vitamin C and D together boosts your immune system and supports bone health. Both vitamins may enhance wound healing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results